Research shows presence of enzyme determines chances of surviving prostate cancer

URO TODAY: For the first time, a study has shown that people who produce excess amounts of an enzyme called elongation factor 1alpha have a better chance of long-term survival from prostate cancer (at least I think that’s what this report says). READ MORE>

Read Full Post »

Undetectable PSA doesn’t always mean prostate cancer hasn’t come back

URO TODAY: Medical researchers have described the case of a 61-year-old man who developed extensive tumours nine years after prostate cancer treatment, even though his PSA level was undetectable. READ MORE>

Read Full Post »

Drug/vaccine combo experiment being tried on advanced prostate cancer

URO TODAY: An experiment that combines a standard advanced prostate cancer drug treatment with a vaccine to assist the immune system has just begun in the US. READ MORE> Looking to harness the body’s own immune system to target prostate cancer that has spread to the bones (metastatic) and is unresponsive to standard treatment, investigators [...]

Read Full Post »

Culprit may have been found in spread of prostate cancer to bone tissue

IN-SCIENCES.ORG: Fucosylations – structures on the surface of prostate cancer cells – trigger prostate cancer cell adhesion inside a blood vessel wall in bone tissue, greatly increasing the prospect of prostate cancer cells metastasizing to bone.

Read Full Post »

Promising new way to find and analyse prostate cancer tumour cells that have spread

URO TODAY: A major obstacle in understanding the biology of advanced prostate cancer is clinicians’ limited ability to obtain metastatic tissue for study.

Read Full Post »

NZ docs too ‘scared’ to try some prostate cancer treatments with proven overseas records

JULY 10: PROSTABLOG NZ: “It’s sad that medical professionals in NZ are so scared of possible side effects from a treatment like Ketoconazole, that they refuse to even acknowledge it, even if it has been proven to be effective overseas.” These words were written today by Mary – a Kiwi whose partner has advanced prostate [...]

Read Full Post »

PROSTATE TREATMENT: Aggressive spinal rebuild gives good result for some with bone metastates

JUNE 30: URO TODAY: In selected patients with prostate cancer metastases to the spine, aggressive surgical decompression and spinal reconstruction is a useful treatment option.

Read Full Post »

PROSTATE HORMONE THERAPY: Measures needed against bone fracture, diabetes, heart risks

JUNE 16: URO TODAY: Preventive measures against adverse effects and careful assessment of a patient’s baseline health status should be considered when using androgen deprivation therapy, say researchers in Texas.

Read Full Post »

PROSTATE RESEARCH: Human antibody cuts bone fracture in patients on hormone therapy

JUNE 13: CANCER CONSULTANTS.COM: Researchers report that treatment with human antibody denosumab significantly reduces the incidence of bone fracture in prostate cancer patients on androgen deprivation therapy.

Read Full Post »

PROSTATE SAGA: NZ way behind US in basic treatments for prostate cancer

MAY 30: PROSTABLOG NZ: The partner of a NZ man with advancing prostate cancer says the public health system can’t test him for bone deterioration for at least year

Read Full Post »